GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (LTS:0QNO) » Definitions » Debt-to-Equity

Lonza Group (LTS:0QNO) Debt-to-Equity : 0.41 (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Lonza Group Debt-to-Equity?

Lonza Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was CHF155 Mil. Lonza Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was CHF3,640 Mil. Lonza Group's Total Stockholders Equity for the quarter that ended in Jun. 2024 was CHF9,351 Mil. Lonza Group's debt to equity for the quarter that ended in Jun. 2024 was 0.41.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Lonza Group's Debt-to-Equity or its related term are showing as below:

LTS:0QNO' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.24   Med: 0.59   Max: 1.06
Current: 0.41

During the past 13 years, the highest Debt-to-Equity Ratio of Lonza Group was 1.06. The lowest was 0.24. And the median was 0.59.

LTS:0QNO's Debt-to-Equity is ranked worse than
60.21% of 191 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.27 vs LTS:0QNO: 0.41

Lonza Group Debt-to-Equity Historical Data

The historical data trend for Lonza Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group Debt-to-Equity Chart

Lonza Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.56 0.28 0.24 0.33

Lonza Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.24 0.28 0.33 0.41

Competitive Comparison of Lonza Group's Debt-to-Equity

For the Diagnostics & Research subindustry, Lonza Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lonza Group's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Lonza Group's Debt-to-Equity falls into.



Lonza Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Lonza Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Lonza Group's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lonza Group  (LTS:0QNO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Lonza Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Lonza Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Lonza Group Business Description

Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

Lonza Group Headlines

No Headlines